Sumitomo Mitsui Trust Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $403M | Sell |
14,366,414
-765,037
| -5% | -$20.4M | 0.26% | 77 |
|
|
2025
Q4 | $377M | Sell |
15,131,451
-483,467
| -3% | -$12.2M | 0.22% | 92 |
|
|
2025
Q3 | $398M | Buy |
15,614,918
+13,802
| +0.1% | +$341K | 0.23% | 87 |
|
|
2025
Q2 | $378M | Buy |
15,601,116
+2,466,969
| +19% | +$57.5M | 0.24% | 90 |
|
|
2025
Q1 | $333M | Sell |
13,134,147
-941,490
| -7% | -$24.6M | 0.24% | 92 |
|
|
2024
Q4 | $373M | Buy |
14,075,637
+956,873
| +7% | +$26M | 0.25% | 76 |
|
|
2024
Q3 | $380M | Buy |
13,118,764
+544,418
| +4% | +$15.9M | 0.26% | 77 |
|
|
2024
Q2 | $352M | Sell |
12,574,346
-3,022,827
| -19% | -$83.2M | 0.26% | 78 |
|
|
2024
Q1 | $433M | Sell |
15,597,173
-109,778
| -0.7% | -$3.05M | 0.3% | 66 |
|
|
2023
Q4 | $452M | Buy |
15,706,951
+115,392
| +0.7% | +$3.49M | 0.33% | 57 |
|
|
2023
Q3 | $517M | Sell |
15,591,559
-185,477
| -1% | -$6.56M | 0.42% | 39 |
|
|
2023
Q2 | $579M | Sell |
15,777,036
-1,507,864
| -9% | -$58.7M | 0.45% | 39 |
|
|
2023
Q1 | $705M | Sell |
17,284,900
-848,833
| -5% | -$36.7M | 0.53% | 29 |
|
|
2022
Q4 | $929M | Sell |
18,133,733
-172,705
| -0.9% | -$8.28M | 0.74% | 18 |
|
|
2022
Q3 | $801M | Sell |
18,306,438
-114,005
| -0.6% | -$5.54M | 0.66% | 19 |
|
|
2022
Q2 | $966M | Buy |
18,420,443
+705,664
| +4% | +$36M | 0.74% | 17 |
|
|
2022
Q1 | $917M | Sell |
17,714,779
-114,775
| -0.6% | -$5.96M | 0.61% | 21 |
|
|
2021
Q4 | $1.05B | Sell |
17,829,554
-258,007
| -1% | -$12.8M | 0.64% | 20 |
|
|
2021
Q3 | $778M | Buy |
18,087,561
+10,382
| +0.1% | +$460K | 0.48% | 36 |
|
|
2021
Q2 | $708M | Sell |
18,077,179
-1,241,896
| -6% | -$48.3M | 0.42% | 45 |
|
|
2021
Q1 | $700M | Sell |
19,319,075
-207,564
| -1% | -$7.37M | 0.44% | 46 |
|
|
2020
Q4 | $719M | Sell |
19,526,639
-3,961,212
| -17% | -$145M | 0.46% | 40 |
|
|
2020
Q3 | $818M | Sell |
23,487,851
-2,211,558
| -9% | -$77.5M | 0.55% | 32 |
|
|
2020
Q2 | $797M | Sell |
25,699,409
-430,566
| -2% | -$14.6M | 0.56% | 30 |
|
|
2020
Q1 | $809M | Buy |
26,129,975
+1,857,632
| +8% | +$63.3M | 0.7% | 22 |
|
|
2019
Q4 | $902M | Buy |
24,272,343
+564,734
| +2% | +$20.1M | 0.71% | 26 |
|
|
2019
Q3 | $808M | Buy |
23,707,609
+389,561
| +2% | +$14.2M | 0.7% | 30 |
|
|
2019
Q2 | $958M | Sell |
23,318,048
-1,181,432
| -5% | -$46.9M | 0.86% | 20 |
|
|
2019
Q1 | $987M | Buy |
24,499,480
+314,324
| +1% | +$12.6M | 0.91% | 18 |
|
|
2018
Q4 | $986M | Buy |
24,185,156
+2,937,318
| +14% | +$122M | 1.06% | 12 |
|
|
2018
Q3 | $888M | Buy |
21,247,838
+142,633
| +0.7% | +$5.49M | 0.96% | 14 |
|
|
2018
Q2 | $726M | Buy |
21,105,205
+1,201,220
| +6% | +$41M | 0.85% | 19 |
|
|
2018
Q1 | $670M | Buy |
19,903,985
+732,742
| +4% | +$25.2M | 0.86% | 17 |
|
|
2017
Q4 | $659M | Buy |
19,171,243
+260,662
| +1% | +$8.89M | 0.85% | 21 |
|
|
2017
Q3 | $641M | Buy |
18,910,581
+25,930
| +0.1% | +$833K | 0.9% | 16 |
|
|
2017
Q2 | $602M | Buy |
18,884,651
+569,366
| +3% | +$18M | 0.88% | 17 |
|
|
2017
Q1 | $594M | Buy |
18,315,285
+178,203
| +1% | +$5.62M | 0.92% | 17 |
|
|
2016
Q4 | $559M | Sell |
18,137,082
-356,998
| -2% | -$10.9M | 0.91% | 18 |
|
|
2016
Q3 | $594M | Sell |
18,494,080
-380,177
| -2% | -$12.7M | 0.97% | 16 |
|
|
2016
Q2 | $631M | Buy |
18,874,257
+141,282
| +0.8% | +$4.51M | 1.09% | 13 |
|
|
2016
Q1 | $527M | Buy |
18,732,975
+561,565
| +3% | +$16M | 0.92% | 17 |
|
|
2015
Q4 | $565M | Buy |
18,171,410
+371,934
| +2% | +$11.7M | 1.01% | 14 |
|
|
2015
Q3 | $530M | Buy |
17,799,476
+703,581
| +4% | +$22.6M | 1.03% | 12 |
|
|
2015
Q2 | $544M | Sell |
17,095,895
-1,364,069
| -7% | -$44.5M | 0.98% | 11 |
|
|
2015
Q1 | $609M | Buy |
18,459,964
+1,316,274
| +8% | +$41.8M | 1.1% | 11 |
|
|
2014
Q4 | $510M | Sell |
17,143,690
-354,155
| -2% | -$10.2M | 0.99% | 11 |
|
|
2014
Q3 | $491M | Sell |
17,497,845
-214,161
| -1% | -$6.01M | 0.98% | 12 |
|
|
2014
Q2 | $499M | Sell |
17,712,006
-403,449
| -2% | -$11.5M | 1.02% | 12 |
|
|
2014
Q1 | $552M | Sell |
18,115,455
-654,404
| -3% | -$19.5M | 1.16% | 10 |
|
|
2013
Q4 | $547M | Sell |
18,769,859
-1,079,317
| -5% | -$31.4M | 1.13% | 11 |
|
|
2013
Q3 | $541M | Sell |
19,849,176
-1,005,013
| -5% | -$27.3M | 1.17% | 10 |
|
|
2013
Q2 | $550M | Buy |
+20,854,189
| New | +$576M | 1.25% | 12 |
|
Other funds holding PFE
VCM
VPM
Sumitomo Mitsui Trust Group's PFE Position: Q1 2026 in Review
Sumitomo Mitsui Trust Group reduced its Pfizer (PFE) stake by 5.1% in Q1 2026, selling an estimated $20.4M and leaving 14,366,414 shares worth $403M. The position accounts for 0.26% of the portfolio, ranked #77.
Sumitomo Mitsui Trust Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.05B in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Sumitomo Mitsui Trust Group held 14,366,414 shares of Pfizer worth $403M as of Q1 2026.
- Sumitomo Mitsui Trust Group sold 765,037 Pfizer shares in Q1 2026, an estimated $20.4M.
- Pfizer made up 0.26% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #77 holding.
- Sumitomo Mitsui Trust Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Sumitomo Mitsui Trust Group's Pfizer position peaked at $1.05B in Q4 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.